Literature DB >> 26272959

Malignant cutaneous lesions.

Daniel H van Raalte1, Cathrien Beishuizen2, Marloes D Stradmeijer2, Ilse Houtenbos2, Reinier W ten Kate2.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26272959      PMCID: PMC4550942          DOI: 10.1136/bcr-2015-210169

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


× No keyword cloud information.
  5 in total

Review 1.  Cutaneous T-cell lymphoma: 2014 update on diagnosis, risk-stratification, and management.

Authors:  Ryan A Wilcox
Journal:  Am J Hematol       Date:  2014-08       Impact factor: 10.047

Review 2.  Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic review.

Authors:  Yang Shi; Endi Wang
Journal:  Arch Pathol Lab Med       Date:  2014-04       Impact factor: 5.534

Review 3.  WHO-EORTC classification for cutaneous lymphomas.

Authors:  Rein Willemze; Elaine S Jaffe; Günter Burg; Lorenzo Cerroni; Emilio Berti; Steven H Swerdlow; Elisabeth Ralfkiaer; Sergio Chimenti; José L Diaz-Perez; Lyn M Duncan; Florent Grange; Nancy Lee Harris; Werner Kempf; Helmut Kerl; Michael Kurrer; Robert Knobler; Nicola Pimpinelli; Christian Sander; Marco Santucci; Wolfram Sterry; Maarten H Vermeer; Janine Wechsler; Sean Whittaker; Chris J L M Meijer
Journal:  Blood       Date:  2005-02-03       Impact factor: 22.113

Review 4.  Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy.

Authors:  Wasif Riaz; Ling Zhang; Pedro Horna; Lubomir Sokol
Journal:  Cancer Control       Date:  2014-10       Impact factor: 3.302

Review 5.  Aggressive mature natural killer cell neoplasms: from epidemiology to diagnosis.

Authors:  Margarida Lima
Journal:  Orphanet J Rare Dis       Date:  2013-07-01       Impact factor: 4.123

  5 in total
  1 in total

Review 1.  Renal sarcoidosis.

Authors:  Marta Calatroni; Gabriella Moroni; Francesco Reggiani; Claudio Ponticelli
Journal:  J Nephrol       Date:  2022-06-27       Impact factor: 4.393

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.